Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Pfizer
Teva Branded Pharmaceutical Products R&D, Inc.
University of Chicago
Yale University
M.D. Anderson Cancer Center
Transgene
Astellas Pharma Inc
Herlev Hospital
NuCana plc
Mayo Clinic
Mural Oncology, Inc
M.D. Anderson Cancer Center
Turnstone Biologics, Corp.
Seagen Inc.
Turnstone Biologics, Corp.
Immodulon Therapeutics Ltd
Astellas Pharma Inc
Inhibrx Biosciences, Inc
Hoosier Cancer Research Network
Karyopharm Therapeutics Inc
Merck Sharp & Dohme LLC
ADC Therapeutics S.A.
Portage Biotech
Atreca, Inc.
University of Florida
Canadian Cancer Trials Group
Rutgers, The State University of New Jersey
Oncorus, Inc.
4D pharma plc
Seagen Inc.
Lumos Pharma
QBiotics Group Limited
Advaxis, Inc.
Columbia University
Repertoire Immune Medicines
Amgen
Lumos Pharma
University of Washington
Exicure, Inc.
University of Pittsburgh
Dynavax Technologies Corporation
Incyte Corporation
Icahn School of Medicine at Mount Sinai
KitovPharma
Incyte Corporation
Royal Marsden NHS Foundation Trust
Daiichi Sankyo
Celldex Therapeutics